Viewing Study NCT03090360


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-01-03 @ 4:47 PM
Study NCT ID: NCT03090360
Status: COMPLETED
Last Update Posted: 2019-07-05
First Post: 2017-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Growth of Infants Fed a New Term Infant Formula
Sponsor: Société des Produits Nestlé (SPN)
Organization:

Study Overview

Official Title: Growth of Infants Fed a New Term Infant Formula With a Prebiotic
Status: COMPLETED
Status Verified Date: 2019-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the growth of healthy term infants fed an experimental infant formula with a prebiotic, a commercial control infant formula with a probiotic, but without a prebiotic and human breast milk
Detailed Description: Multisite, double-blind, randomized, controlled clinical trial. The purpose of the study is to determine if infants fed a standard infant formula with a prebiotic have a weight gain in line with infants fed a standard starter infant formula without a prebiotic.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: